Comparative analysis of diagnostic methods for the detection of Cryptococcus neoformans meningitis
暂无分享,去创建一个
P. Criado | M. V. da Silva | T. M. B. de Almeida | K. Dantas | Roseli Santos de Freitas-Xavier | Alfredo Mendroni Júnior | V. T. de Freitas | Suzete Cleusa Ferreira Spina Lombardi
[1] D. Boulware,et al. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. , 2022, The Lancet. Infectious diseases.
[2] S. Suerbaum,et al. Comparison of a Lateral Flow Assay and a Latex Agglutination Test for the Diagnosis of Cryptococcus Neoformans Infection , 2021, Current Microbiology.
[3] C. Vianna,et al. Cost-effectiveness analysis and budgetary impact of the Cryptococcal Antigen Lateral Flow Assay (CRAG-LFA) implementation for the screening and diagnosis of cryptococcosis in asymptomatic people living with HIV in Brazil , 2021, Revista do Instituto de Medicina Tropical de Sao Paulo.
[4] D. Boulware,et al. Evaluation of the Diagnostic Performance of a Semiquantitative Cryptococcal Antigen Point-of-Care Assay among HIV-Infected Persons with Cryptococcal Meningitis , 2021, Journal of clinical microbiology.
[5] A. Bhigjee,et al. Review of the neurological aspects of HIV infection , 2021, Journal of the Neurological Sciences.
[6] P. Saldiva,et al. A single-centre, retrospective study of the incidence of invasive fungal infections during 85 years of autopsy service in Brazil , 2021, Scientific Reports.
[7] B. Kuehn. Pulmonary Fungal Infections Affect Patients With COVID-19. , 2020, JAMA.
[8] D. Boulware,et al. The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015–2017 , 2019, Open forum infectious diseases.
[9] Adeno Gonçalves Oliveira,et al. Mortality by cryptococcosis in Brazil from 2000 to 2012: A descriptive epidemiological study , 2019, PLoS neglected tropical diseases.
[10] Wanshui Shan,et al. Development of a lateral flow recombinase polymerase amplification assay for rapid and visual detection of Cryptococcus neoformans/C. gattii in cerebral spinal fluid , 2019, BMC Infectious Diseases.
[11] L. Goldani,et al. Molecular types of Cryptococcus species isolated from patients with cryptococcal meningitis in a Brazilian tertiary care hospital , 2018, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[12] D. Boulware,et al. Cryptococcal Meningitis Diagnostics and Screening in the Era of Point-of-Care Laboratory Testing , 2018, Journal of Clinical Microbiology.
[13] S. Jaffar,et al. Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus–associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] J. Błaszkowska,et al. Neuroinfections caused by fungi , 2018, Infection.
[15] E. Castañeda,et al. The status of cryptococcosis in Latin America , 2018, Memorias do Instituto Oswaldo Cruz.
[16] D. Boulware,et al. Performance of cryptococcal antigen lateral flow assay in serum, cerebrospinal fluid, whole blood, and urine in HIV-infected patients with culture-proven cryptococcal meningitis admitted at a Brazilian referral center , 2018, Revista do Instituto de Medicina Tropical de Sao Paulo.
[17] O. Luiz,et al. Comparison of diagnostic methods to detect Histoplasma capsulatum in serum and blood samples from AIDS patients , 2018, PloS one.
[18] A. Limper,et al. Fungal infections in HIV/AIDS. , 2017, The Lancet. Infectious diseases.
[19] D. Boulware,et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. , 2017, The Lancet. Infectious diseases.
[20] A. S. Borges,et al. The epidemiology of cryptococcosis and the characterization of Cryptococcus neoformans isolated in a Brazilian University Hospital , 2017, Revista do Instituto de Medicina Tropical de Sao Paulo.
[21] Yue Zhao,et al. Current diagnosis and treatment of cryptococcal meningitis without acquired immunodeficiency syndrome , 2016 .
[22] D. Boulware,et al. Reproducibility of CSF quantitative culture methods for estimating rate of clearance in cryptococcal meningitis. , 2016, Medical mycology.
[23] D. Boulware,et al. LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITY , 2015, Revista do Instituto de Medicina Tropical de Sao Paulo.
[24] K. Ashizawa,et al. Clinical features of pulmonary cryptococcosis in non-HIV patients in Japan. , 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[25] M. Martins,et al. Molecular diagnosis of cryptococcal meningitis in cerebrospinal fluid: comparison of primer sets for Cryptococcus neoformans and Cryptococcus gattii species complex , 2014, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[26] Daniel Wagner Castro Lima Santos,et al. Epidemiology of Invasive Fungal Infections in Patients with Acquired Immunodeficiency Syndrome at a Reference Hospital for Infectious Diseases in Brazil , 2014, Mycopathologia.
[27] D. Castelo-Branco,et al. Molecular methods for the diagnosis and characterization of Cryptococcus: a review. , 2010, Canadian journal of microbiology.
[28] J. Perfect,et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] Luiz Carlos Severo,et al. Capítulo 3: criptococose pulmonar , 2009 .
[30] I. Xess,et al. Detection of Cryptococcus by conventional, serological and molecular methods. , 2009, Journal of medical microbiology.
[31] L. Travassos,et al. Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. , 2009, Memorias do Instituto Oswaldo Cruz.
[32] S. Antinori,et al. AIDS‐associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre‐ and post‐HAART eras. Experience of a single centre in Italy , 2009, HIV medicine.
[33] M. Capoor,et al. Clinical and mycological profile of cryptococcosis in a tertiary care hospital. , 2007, Indian journal of medical microbiology.
[34] J. Heitman,et al. Cryptococcus neoformans Mates on Pigeon Guano: Implications for the Realized Ecological Niche and Globalization , 2007, Eukaryotic Cell.
[35] K. Kwon-Chung,et al. Do major species concepts support one, two or more species within Cryptococcus neoformans? , 2006, FEMS yeast research.
[36] A. Iwamoto,et al. Utility of Testing Bronchoalveolar Lavage Fluid for Cryptococcal Ribosomal DNA , 2003, The Journal of international medical research.
[37] M. Vainstein,et al. Molecular typing of clinical and environmental Cryptococcus neoformans isolates in the Brazilian state Rio Grande do Sul. , 2003, FEMS yeast research.
[38] E. Graviss,et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[39] B. Wanke,et al. Serotyping of 467 Cryptococcus neoformans Isolates from Clinical and Environmental Sources in Brazil: Analysis of Host and Regional Patterns , 2003, Journal of Clinical Microbiology.
[40] J. Graybill,et al. Detection of Cryptococcus neoformans DNA in Tissue Samples by Nested and Real-Time PCR Assays , 2002, Clinical and Vaccine Immunology.
[41] T. Boekhout,et al. (1557) Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae) , 2002 .
[42] Y. Senda,et al. Multiplex PCR Using Internal Transcribed Spacer 1 and 2 Regions for Rapid Detection and Identification of Yeast Strains , 2001, Journal of Clinical Microbiology.
[43] K. Nishimura,et al. New PCR Primer Pairs Specific for Cryptococcus neoformans Serotype A or B Prepared on the Basis of Random Amplified Polymorphic DNA Fingerprint Pattern Analyses , 1999, Journal of Clinical Microbiology.
[44] P. Rappelli,et al. Development of a Nested PCR for Detection ofCryptococcus neoformans in Cerebrospinal Fluid , 1998, Journal of Clinical Microbiology.
[45] T. G. Mitchell,et al. Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans , 1995, Clinical microbiology reviews.
[46] T. G. Mitchell,et al. Unique oligonucleotide primers in PCR for identification of Cryptococcus neoformans , 1994, Journal of clinical microbiology.
[47] L. Ercolani,et al. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. , 1988, The Journal of biological chemistry.
[48] William H. Barker,et al. CLINICAL EPIDEMIOLOGY: THE ESSENTIALS. , 1984 .
[49] A. Forrestel,et al. CRYPTOCOCCOSIS , 1982, The Lancet.
[50] K. Kwon-Chung,et al. Epidemiologic differences among serotypes of Cryptococcus neoformans. , 1977, American journal of epidemiology.
[51] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[52] Jacob Cohen. A Coefficient of Agreement for Nominal Scales , 1960 .
[53] J. Wilt,et al. Medical Mycology , 1944, Nature.
[54] C. Kauffman,et al. Detection of cryptococcal antigen. Comparison of two latex agglutination tests. , 1981, American journal of clinical pathology.
[55] L. Ajello,et al. Laboratory manual for medical mycology. , 1962 .